• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[作为蛋白质合成调节剂的S-腺苷甲硫氨酸。对血浆纤维蛋白原的影响]

[S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].

作者信息

Frezza M, Pozzato G, Valente G, Gilotta S, Milani S, Nicolini R

出版信息

Minerva Med. 1977 Apr 7;68(17):1105-14.

PMID:857203
Abstract

S-adenosyl-L-methionine (SAMe) is a physiological compound which plays an important role in numerous biological processes, such as transmethylations, transulphurations and aminopropylations. Starting from a study about the usefulness of the SAMe to normalize protein synthesis in old age, the drug was found to have an interesting action with respect to fibrinogen. Later research regarding a large number of patients, led us to discover after treatment for 40 days with 60 mg/die of SAMe, highly significant variations in fibrinogen values with constant normalization of this parameter, in both hypo- and hyper-fibrinogenemia. So far we don't know anything about the action of the drug on various metabolic stages of the fibrinogen; interestingly however our data exclude a rise in fibrinolysis.

摘要

S-腺苷-L-甲硫氨酸(SAMe)是一种生理化合物,在众多生物过程中发挥着重要作用,如转甲基作用、转硫作用和氨丙基化作用。从一项关于SAMe对老年蛋白质合成正常化作用的研究开始,发现该药物对纤维蛋白原有有趣的作用。后来针对大量患者的研究,使我们发现在用60毫克/日的SAMe治疗40天后,无论在低纤维蛋白原血症还是高纤维蛋白原血症中,纤维蛋白原值都有高度显著的变化,且该参数持续正常化。到目前为止,我们对该药物在纤维蛋白原不同代谢阶段的作用一无所知;然而有趣的是,我们的数据排除了纤维蛋白溶解增加的可能性。

相似文献

1
[S-adenosylmethionine as a regulator of protein synthesis. Influence on plasmatic fibrinogen].[作为蛋白质合成调节剂的S-腺苷甲硫氨酸。对血浆纤维蛋白原的影响]
Minerva Med. 1977 Apr 7;68(17):1105-14.
2
[Relations between protidopoiesis and biological transmethylations: action of S-adenosylmethionine on protein crasis in chronic hepatopathies].[蛋白质生成与生物转甲基作用之间的关系:S-腺苷甲硫氨酸对慢性肝病中蛋白质组成的作用]
Minerva Med. 1975 May 2;66(33):1581-9.
3
Blood viscosity and red cell morphology in subjects suffering from cirrhosis before and after treatment with S-adenosyl-L-methionine (SAM).肝硬化患者在接受S-腺苷-L-蛋氨酸(SAM)治疗前后的血液粘度和红细胞形态
Clin Hemorheol Microcirc. 2000;22(3):215-21.
4
[Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].[用S-腺苷-L-蛋氨酸治疗慢性/高氨血症性肝病期间氨血症的表现]
Clin Ter. 1980 Mar 31;92(6):587-602.
5
[Therapeutic action of S-adenosylmethionine in some chronic hepatopathies].[S-腺苷甲硫氨酸在某些慢性肝病中的治疗作用]
Minerva Med. 1975 May 2;66(33):1563-70.
6
[S-Adenosylmethionine: plasma levels in hepatic cirrhosis and preliminary results of its clinical use in hepatology. Double-blind study].[S-腺苷甲硫氨酸:肝硬化患者的血浆水平及其在肝病临床应用的初步结果。双盲研究]
Minerva Med. 1975 May 2;66(33):1571-80.
7
[New trends in the therapy of chronic liver diseases. Significance of Sam-dependent transmethylations].[慢性肝病治疗的新趋势。S-腺苷甲硫氨酸依赖性转甲基作用的意义]
Minerva Gastroenterol. 1974 Jan-Mar;20(1):19-26.
8
[Effectiveness of S-adenosylmethionine (SAM) in the treatment of chronic liver diseases].[S-腺苷甲硫氨酸(SAM)治疗慢性肝病的疗效]
Clin Ter. 1980 Feb 15;92(3):241-50.
9
[The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
Minerva Med. 1978 Oct 13;69(48):3283-92.
10
[Changes in the lactate dehydrogenase level and in other laboratory parameters during treatment with S-adenosyl-l-methionine in children with acute articular rheumatism].[急性关节风湿症患儿接受S-腺苷-L-蛋氨酸治疗期间乳酸脱氢酶水平及其他实验室参数的变化]
Minerva Pediatr. 1978 Feb 15;30(3):265-70.

引用本文的文献

1
Localization of S-[methyl-14 C]adenosyl-L-methionine in pregnant mice and fetuses as determined by autoradiography.
Eur J Drug Metab Pharmacokinet. 1979;4(3):157-61. doi: 10.1007/BF03189419.